Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
Grant revenues	$ 74,534
Operating expenses:
General and administrative, including $1,960,000 to related parties for the three months ended March 31, 2014	229,900	$ 2,348,107
Research and development, including $76,500 to a related party for the three months ended March 31, 2015	440,792	64,089
Total operating expenses	670,692	2,412,196
Loss from operations	(596,158)	(2,412,196)
Gain on settlements with former management	92,550	1,038,270
Interest expense, including $11,993 and $12,046 to related parties for the three months ended March 31, 2015 and 2014, respectively	(228,534)	(13,061)
Foreign currency transaction gain	4,190	6,277
Net loss	$ (727,952)	(1,380,710)
Adjustments related to Series G 1.5% Convertible Preferred Stock:
Amortization of deemed dividend on Series G 1.5% Convertible Preferred Stock		(1,209,970)
Dividend on Series G 1.5% Convertible Preferred Stock	$ (3,198)	(408)
Net loss attributable to common stockholders	$ (731,150)	$ (2,591,088)
Net loss per common share - basic and diluted	$ 0.00	$ (.02)
Weighted average common shares outstanding - basic and diluted	238,705,800	152,274,889